Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 590

1.

Human Immunodeficiency Virus Infection and Incident Atrial Fibrillation.

Sardana M, Hsue PY, Tseng ZH, Vittinghoff E, Nah G, Dewland TA, Marcus GM.

J Am Coll Cardiol. 2019 Sep 17;74(11):1512-1514. doi: 10.1016/j.jacc.2019.07.027. No abstract available.

PMID:
31514955
2.

Predictors for Blood Pressure Reduction in American Latinos: Secondary Analysis of the Adelgaza Program Data.

Li WW, Vittinghoff E, Fukuoka Y.

Hisp Health Care Int. 2019 Sep 11:1540415319869936. doi: 10.1177/1540415319869936. [Epub ahead of print]

PMID:
31505970
3.

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.

Kohli-Lynch CN, Bellows BK, Thanassoulis G, Zhang Y, Pletcher MJ, Vittinghoff E, Pencina MJ, Kazi D, Sniderman AD, Moran AE.

JAMA Cardiol. 2019 Aug 28. doi: 10.1001/jamacardio.2019.2851. [Epub ahead of print]

PMID:
31461121
4.

Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial.

Lown EA, Banerjee A, Vittinghoff E, Dvorak CC, Hartogensis W, Melton A, Mangurian C, Hu H, Shear D, Adcock R, Morgan M, Golden C, Hecht FM.

Glob Adv Health Med. 2019 Aug 14;8:2164956119870444. doi: 10.1177/2164956119870444. eCollection 2019.

5.

Applying machine learning to predict future adherence to physical activity programs.

Zhou M, Fukuoka Y, Goldberg K, Vittinghoff E, Aswani A.

BMC Med Inform Decis Mak. 2019 Aug 22;19(1):169. doi: 10.1186/s12911-019-0890-0.

6.

Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics.

Scott HM, Spinelli M, Vittinghoff E, Morehead-Gee A, Hirozawa A, James C, Hammer H, Liu A, Gandhi M, Buchbinder S.

AIDS. 2019 Aug 20. doi: 10.1097/QAD.0000000000002347. [Epub ahead of print]

PMID:
31436610
7.

Follow-up of incidental pulmonary nodules and association with mortality in a safety-net cohort.

Lee JS, Lisker S, Vittinghoff E, Cherian R, McCoy DB, Rybkin A, Su G, Sarkar U.

Diagnosis (Berl). 2019 May 9. pii: /j/dx.ahead-of-print/dx-2019-0008/dx-2019-0008.xml. doi: 10.1515/dx-2019-0008. [Epub ahead of print]

PMID:
31373897
8.

Home-based tuberculosis contact investigation in Uganda: a household randomised trial.

Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, Mark D, Babirye D, Okello DA, Mugabe F, Fair E, Vittinghoff E, Armstrong-Hough M, Dowdy D, Cattamanchi A, Haberer JE, Katamba A.

ERJ Open Res. 2019 Jul 29;5(3). pii: 00112-2019. doi: 10.1183/23120541.00112-2019. eCollection 2019 Jul.

9.

Development and Validation of the Personalized Sexual Health Promotion (SexPro) HIV Risk Prediction Model for Men Who Have Sex with Men in the United States.

Scott H, Vittinghoff E, Irvin R, Liu A, Nelson L, Del Rio C, Magnus M, Mannheimer S, Fields S, Van Tieu H, Kuo I, Shoptaw S, Grinsztejn B, Sanchez J, Wakefield S, Fuchs JD, Wheeler D, Mayer KH, Koblin BA, Buchbinder S.

AIDS Behav. 2019 Jul 27. doi: 10.1007/s10461-019-02616-3. [Epub ahead of print]

PMID:
31352633
10.

Housing First: Unsuppressed Viral Load Among Women Living with HIV in San Francisco.

Riley ED, Vittinghoff E, Koss CA, Christopoulos KA, Clemenzi-Allen A, Dilworth SE, Carrico AW.

AIDS Behav. 2019 Jul 19. doi: 10.1007/s10461-019-02601-w. [Epub ahead of print]

PMID:
31324996
11.

Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events.

Zhang Y, Vittinghoff E, Pletcher MJ, Allen NB, Zeki Al Hazzouri A, Yaffe K, Balte PP, Alonso A, Newman AB, Ives DG, Rana JS, Lloyd-Jones D, Vasan RS, Bibbins-Domingo K, Gooding HC, de Ferranti SD, Oelsner EC, Moran AE.

J Am Coll Cardiol. 2019 Jul 23;74(3):330-341. doi: 10.1016/j.jacc.2019.03.529.

12.

Real-world heart rate norms in the Health eHeart study.

Avram R, Tison GH, Aschbacher K, Kuhar P, Vittinghoff E, Butzner M, Runge R, Wu N, Pletcher MJ, Marcus GM, Olgin J.

NPJ Digit Med. 2019 Jun 25;2:58. doi: 10.1038/s41746-019-0134-9. eCollection 2019.

13.

Refining the World Health Organization Definition.

Tseng ZH, Salazar JW, Olgin JE, Ursell PC, Kim AS, Bedigian A, Probert J, Hart AP, Moffatt E, Vittinghoff E.

Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007171. doi: 10.1161/CIRCEP.119.007171. Epub 2019 Jun 28.

PMID:
31248279
14.

Effectiveness and cost of organized outreach for colorectal cancer screening: A Randomized Controlled Trial.

Somsouk M, Rachocki C, Mannalithara A, Garcia D, Laleau V, Grimes B, Issaka RB, Chen E, Vittinghoff E, Shapiro JA, Ladabaum U.

J Natl Cancer Inst. 2019 Jun 12. pii: djz110. doi: 10.1093/jnci/djz110. [Epub ahead of print]

PMID:
31187126
15.

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

Coffin PO, Santos GM, Behar E, Hern J, Walker J, Matheson T, Kinnard EN, Silvis J, Vittinghoff E, Fox R, Page K.

PLoS One. 2019 Jun 3;14(6):e0217471. doi: 10.1371/journal.pone.0217471. eCollection 2019.

16.

Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States.

Hirode G, Vittinghoff E, Wong RJ.

J Clin Gastroenterol. 2019 May 22. doi: 10.1097/MCG.0000000000001229. [Epub ahead of print]

PMID:
31135632
17.
18.

Risk Factors Associated With Atrioventricular Block.

Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM.

JAMA Netw Open. 2019 May 3;2(5):e194176. doi: 10.1001/jamanetworkopen.2019.4176.

19.

Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.

Sharpton SR, Maraj B, Harding-Theobald E, Vittinghoff E, Terrault NA.

Am J Clin Nutr. 2019 May 24. pii: nqz042. doi: 10.1093/ajcn/nqz042. [Epub ahead of print]

PMID:
31124558
20.

Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.

Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY.

J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):158-162. doi: 10.1097/QAI.0000000000002005.

PMID:
31095005

Supplemental Content

Loading ...
Support Center